IDH1 and neoplasm: Probabilities of tumor recurrence after resection at 1, 4 and 7 years in patients with mIDH1/2 iCCA (10.5%, 45.3% and 45.3%, respectively) were significantly lower than those with wild-type IDH1 or IDH2 (41.7%, 71.5% and 81.3%, respectively).